(1 - 9 von 13
)
FDA approves Biogen drug for lead genetic cause of infant death |...
www.reuters.com
The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in...
George Scangos - Latest News and breaking headlines - Benzinga
www.benzinga.com
Following an announcement by Biogen Inc (NASDAQ: BIIB) elevating Michel Vounatsos, the company's chief commercial officer and a recent ...
Biogen's stock jumps after results beat expectations; CEO to leave -...
www.marketwatch.com
Biogen Inc.'s stock undefined surged 5.3% in premarket trade Thursday, after the biotechnology company beat second-quarter earnings and revenue expectations...
sortiert nach Relevanz / Datum